Modified Glasgow prognostic score as a prognostic factor for renal cell carcinomas: a systematic review and meta-analysis.

Hu, Xu; Wang, Yan; Yang, Wei-Xiao; Dou, Wei-Chao; Shao, Yan-Xiang; Li, Xiang

Hu, Xu; Wang, Yan; Yang, Wei-Xiao; Dou, Wei-Chao; Shao, Yan-Xiang; Li, Xiang.

Afiliação

Hu X; West China School of Medicine/West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Wang Y; West China School of Medicine/West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Yang WX; West China School of Medicine/West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Dou WC; West China School of Medicine/West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Shao YX; West China School of Medicine/West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Li X; Department of Urology, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China.

Cancer Manag Res ; 11: 6163-6173, 2019.

Article em En | MEDLINE | ID: mdl-31308752

Palavras-chave

meta-analysis; modified Glasgow prognostic score; prognosis; renal cell carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Systematic_reviews Idioma: En Revista: Cancer Manag Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google